/viestories/media/media_files/2025/02/03/nmB3FdNmHNA3OAj13yvt.png)
World Cancer Day is observed every year on February 4 to raise awareness and educate people about preventing, identifying and treating this life-threatening disease.
According to the World Health Organization (WHO), cancer was the leading cause of death globally, responsible for nearly 10 million deaths in 2022.
Cancer is one of the leading causes of death worldwide and with the increasing number of cases, the importance of this day has grown even more. The goal of World Cancer Day is not only to raise awareness about the disease but also to promote joint efforts for its prevention, treatment and control.
World Cancer Day 2025: Theme
The theme for World Cancer Day 2025, "United by Unique," highlights the importance of personalized care in the fight against cancer. It focuses on tailoring treatment to meet the specific needs of each person.
In this article we are telling you about the leading startups in cancer treatment in India which are changing the face of Indian healthtech.
Perfint Healthcare
The company develops medical devices aimed at improving image-guided therapies. Their devices are used for minimally invasive ablation procedures, particularly in oncology, helping healthcare professionals improve the quality of life for cancer patients and those in pain.
Niramai
Niramai is a deep tech healthcare company based in Bangalore. It is an ISO 13485:2016 and MDSAP certified company focused on quality. Our main product, Thermalytix, is an innovative breast cancer screening solution that is accurate, portable and automated. It uses patented machine learning algorithms on thermal images to detect early-stage cancer.
ImmunoACT
Founded in 2018, Mumbai-based ImmunoACT develops cell therapies for cancer treatment. The company has a patented CAR-T cell platform with a unique design algorithm to create treatments, including Actalycabtagene autoleucel for B-lymphoid cancers, HCAR2 for multiple myeloma and HCAr3 for glioblastoma multiforme and neuroblastoma.
Zumutor
The Bengaluru-based Zumutor was founded in 2013, Zumutor develops new immunotherapies for cancer treatment. Their main product, ZM008, is an anti-LLT1 mAB for prostate cancer, B-cell lymphoma and glioma. They also have drug candidates ZM012 and ZM014 for lymphoma. Additionally, the company has a unique mAb technology platform called INABLR, which helps quickly identify powerful mAbs that can manage ADCC activity.
Strand Life Sciences
Founded in 2000, the Bengaluru-based Strand Life Sciences offers omics-based solutions for clinical genomics, systems biology, and drug discovery. The company provides sequence-based diagnostics and genomic data interpretation services to healthcare providers. They also offer solutions for integrated omics analysis, image management, systems biology modeling, and molecular modeling.
ZenOnco.io
Established in 2019 by Dimple Parmar and Kishan Shah, ZenOnco.io is India’s first integrative oncology cancer care center. It supports cancer treatment by offering personalized nutrition, fitness, and psychology programs tailored to each stage of treatment: prevention, prehab, cure, rehab, recurrence prevention and palliative care.
4baseCare
Founded in 218, 4baseCare focuses on creating advanced Precision Oncology solutions using genomics and next-gen digital health technology. Recognizing that clinical outcomes can vary across different populations, they have developed unique cancer gene panels that help oncologists choose the best precision therapies for their patients.
Sascan
Founded in 2015 by Dr. Subhash Narayanan and Dr. Ruhi Agarwala, Sascan’s multispectral camera offers a non-invasive, real-time solution for screening and detecting cancer cells in the mouth.
Akrivia Biosciences Pvt Ltd
AKRIVIA is an innovator focused on accurate cancer diagnostics and personalized medicine for different types of cancer. Using their advanced technology, they have created diagnostic tests for various cancers that help design the best treatment plans, leading to better responses and reducing unnecessary treatments.
AiNDRA
Founded in 2012 by Adarsh Natarajan (CEO) and Abhishek Mishra, The AiNDRA system, created by AiNDRA, is an innovative diagnostic tool that uses artificial intelligence (AI) to provide early, affordable, and accurate cervical cancer diagnoses in clinical settings. It offers an alternative to the current standard method of diagnosis and helps eliminate the need for a trained pathologist.